---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278588801.md"
description: "MacroGenics shares are trading higher after the company reported better-than-expected Q4 financial results. Also, Barclays maintained its Overweight rating and raised its price target from $3 to $4."
datetime: "2026-03-10T16:15:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278588801.md)
  - [en](https://longbridge.com/en/news/278588801.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278588801.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/278588801.md) | [繁體中文](https://longbridge.com/zh-HK/news/278588801.md)


# 

MacroGenics shares are trading higher after the company reported better-than-expected Q4 financial results. Also, Barclays maintained its Overweight rating and raised its price target from $3 to $4.

### Related Stocks

- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [MacroGenics, Inc. (MGNX.US)](https://longbridge.com/en/quote/MGNX.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Direxion Daily S&P Biotech Bear 3X ETF (LABD.US)](https://longbridge.com/en/quote/LABD.US.md)

## Related News & Research

- [Tritonpoint Wealth LLC Sells 10,771 Shares of Zoetis Inc. $ZTS](https://longbridge.com/en/news/281684930.md)
- [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/en/news/281174211.md)
- [MSD secures EC clearance for Keytruda combination therapy for ovarian cancer](https://longbridge.com/en/news/281737265.md)
- [FDA Approves Dosing Interval Extension Up To 20 Weeks For EYLEA HD In WAMD And DME](https://longbridge.com/en/news/281744271.md)
- [BUZZ-Context Therapeutics rises as FDA grants fast-track status to ovarian cancer drug](https://longbridge.com/en/news/281517197.md)